FROM NURSE, TO ROLES IN MEDTECH MARKETING, CHAMPIONING WOMEN’S HEALTH
With
Aggie Cox
Government Affairs & Marketing Director – ANZ, Hologic
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | July 2026
Aggie Cox is a senior healthcare marketing leader and women’s health advocate with over two decades of experience spanning clinical care, medical technology, and executive marketing leadership. She currently serves as Government Affairs & Marketing Director for Australia and New Zealand at Hologic, Inc., a global medical technology company dedicated to advancing women’s health through early detection, diagnosis, and treatment.
With an early career as a Registered Nurse, including frontline experience in emergency and trauma care, Aggie brings a rare clinical lens to health leadership—grounding strategy, communication, and advocacy in real patient needs. This foundation has shaped her work in ensuring women’s health messaging is evidence‑based, accessible, and designed to drive real‑world outcomes.
At Hologic, Aggie has been instrumental in elevating attention to under‑recognised and under‑treated women’s health issues, including preventive screening, sexual and reproductive health, and heavy menstrual bleeding. Her leadership has helped normalise conversations often avoided due to stigma, empowering women to seek information, diagnosis, and care earlier.
Aggie is particularly recognised for reframing marketing as a public health lever, not just a commercial function. Her work connects education, awareness, digital innovation, and clinical credibility to improve health literacy and engagement—especially among women who may delay care due to embarrassment, lack of access, or misinformation.
Aggie regularly contributes to national leadership forums, industry conferences, and community events, including International Women’s Day panels and major marketing and customer experience conferences. Her speaking focuses on the intersection of women’s health, leadership, workplace wellbeing, and purpose‑led growth, as well as resilience and non‑linear career pathways for women in leadership.
Aggie holds a Master of Marketing from Melbourne Business School and is widely respected for bridging commercial performance with social impact. She is passionate about making women’s health visible, discussable, and actionable—in healthcare systems, workplaces, and society at large.
Source: Supplied
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
Breaking silos to transform women’s health through MedTech
In an interview with Australian Health Journal, Jasjit Baveja, Director of Regulatory and Industry Policy at the Medical Technology Association of Australia (MTAA), highlighted the growing importance of medical technology in addressing longstanding inequities in women’s health.
Drawing on the outcomes of the inaugural MTAA Women’s Health MedTech Summit, she explained how the event brought together clinicians, researchers, industry leaders, regulators, investors, government representatives and patient advocates to tackle complex challenges through a collaborative approach.
-
Funding roadblocks creating digital health inequity
Helen Souris, CEO and Executive Director of Cardihab and Chair of the Digital Health Advisory Group at the Medical Technology Association of Australia (MTAA), highlights the significant gap in cardiac rehabilitation access across Australia. Despite the proven benefits of cardiac rehabilitation in improving survival, quality of life, and reducing hospital admissions, around 80% of eligible patients do not receive this care, with access rates even lower in regional and rural communities.
